Skyrocketing growth in demand, accelerating security threats, extreme weather events and increasing systemic vulnerabilities ...
CoreWeave's aggressive capex and high leverage drive negative FCF and expose it to refinancing and dilution risk. See why I ...
Victoria Gray spent 34 years battling the debilitating pain of sickle cell disease. Then she volunteered to be the world's first "prototype" for a CRISPR therapy, based on technology invented at UC ...